Can you provide the specific date for apotex's ruxolitinib us filing?

I can help, but I need one detail first: by “Apotex’s ruxolitinib US filing,” do you mean:

1. Apotex’s ANDA filing (abbreviated new drug application) for ruxolitinib in the US, or
2. a Citizen Petition / supplement / amendment, or
3. an FDA acceptance/receipt date versus the initial submission date?

Also, do you mean ruxolitinib tablets (e.g., Jakafi) and what strength(s) (5 mg / 10 mg / 15 mg / 20 mg), or is “ruxolitinib” generally?

If you tell me which one (and ideally the strength/product), I can give you the specific date. If you already have a link or the FDA document number (e.g., from Drugs@FDA, Drugs@FDA “Application number,” or a patent listing tied to the filing), paste it and I’ll pinpoint the exact date.